Vitamin D uptake in chronic kidney disease

niversitätsklinikum der RWTH Aachen0 个研究点目标入组 20 人开始时间: 2022年5月31日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•stable, chronic hemodialysis patients
•Age of = 18 years
•Written informed consent prior to study participation
•The subject is willing and able to follow the procedures outlined in the protocol
•Control group:
•Normal renal function
•Age- and sex-matched as well as written informed consent prior to study participation
•The subject is willing and able to follow the procedures outlined in the protocol

•Age less than 18 years
•Severe medical events within the last month
•Planned surgery within the duration of the sampling
•Acute/chronic gastrointestinal infections
•Recent or ongoing antibiotic therapy
•Conditions that impair vitamin D uptake or metabolism (chronic inflammatory bowel disease)
•Severe dyslipidemia
•Severe anemia, defined as hemoglobin level less than 9.0 g/dl
•Pregnant and lactating females
•Committed to an institution by legal or regulatory order
•Participation in a parallel interventional clinical trial
•Receipt of an investigational drug within 30 days prior to inclusion into this study
•The subject is mentally or legally incapacitated
•Vitamin D supplementation

发起方

niversitätsklinikum der RWTH Aachen